Global High-throughput Screening (HTS) Assay Market Growth (Status and Outlook) 2024-2030

Global High-throughput Screening (HTS) Assay Market Growth (Status and Outlook) 2024-2030

High-throughput screening (HTS) assay is a method used in drug discovery and other fields to quickly and efficiently test a large number of compounds or samples for a specific biological activity. HTS assays are typically automated and can screen thousands to millions of compounds in a relatively short amount of time. HTS assays are often used in the early stages of drug discovery to identify potential lead compounds that show promising activity against a target of interest. These assays can be used to screen for a wide range of biological activities, such as enzyme inhibition, receptor binding, or cell-based assays. There are several different types of HTS assays, including biochemical assays, cell-based assays, and phenotypic assays. Biochemical assays measure the activity of a specific enzyme or protein, while cell-based assays use living cells to measure the effect of compounds on cellular processes. Phenotypic assays measure a specific observable phenotype, such as cell growth or morphology. Overall, HTS assays are a powerful tool in drug discovery and other fields, allowing researchers to quickly and efficiently screen large libraries of compounds to identify potential drug candidates.

The global High-throughput Screening (HTS) Assay market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “High-throughput Screening (HTS) Assay Industry Forecast” looks at past sales and reviews total world High-throughput Screening (HTS) Assay sales in 2022, providing a comprehensive analysis by region and market sector of projected High-throughput Screening (HTS) Assay sales for 2023 through 2029. With High-throughput Screening (HTS) Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High-throughput Screening (HTS) Assay industry.

This Insight Report provides a comprehensive analysis of the global High-throughput Screening (HTS) Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on High-throughput Screening (HTS) Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High-throughput Screening (HTS) Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High-throughput Screening (HTS) Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High-throughput Screening (HTS) Assay.

United States market for High-throughput Screening (HTS) Assay is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for High-throughput Screening (HTS) Assay is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for High-throughput Screening (HTS) Assay is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key High-throughput Screening (HTS) Assay players cover Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of High-throughput Screening (HTS) Assay market by product type, application, key players and key regions and countries.

Segmentation by Type:
Biochemical Assay
Phenotyping Assay
Binding Assay
Aell-based Assay
Others

Segmentation by Application:
Drug Discovery
Identifying New Drug Targets
Toxicology Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Biochemical Assay
Phenotyping Assay
Binding Assay
Aell-based Assay
Others

Segmentation by Application:
Drug Discovery
Identifying New Drug Targets
Toxicology Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
PerkinElmer
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio-Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical

Please note: The report will take approximately 2 business days to prepare and deliver.